Distributed automated manufacturing of pluripotent stem cell products

Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its challenges are recognised by healthcare regulators with deviations and comparability issues receiving specific attention from them. This paper is...

Full description

Saved in:
Bibliographic Details
Published in:Int J Adv Manuf Technol
Main Authors: Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J
Format: Artigo
Language:Inglês
Published: Springer London 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954896/
https://ncbi.nlm.nih.gov/pubmed/31983799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00170-019-04516-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items